Parsel et al.8 reviewed all patients with SMARCB1-deficient cancers of the nasal sinuses reported in the literature and pointed out that the prognosis of this type of tumor was poor and that most of the tumors were in the advanced stage, with a tendency to metastasize at the time of discovery. The gene discussed is SMARCB1; the disease is neoplasm.